✦ LIBER ✦

Long-term benefit of rituximab in MuSK autoantibody myasthenia gravis patients

✍ Scribed by Keung, B.; Robeson, K. R.; DiCapua, D. B.; Rosen, J. B.; O'Connor, K. C.; Goldstein, J. M.; Nowak, R. J.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

G.P.11.08 Long term remissions in MuSK-p

✍ J. Michaels; T. Ranjan; J.R. Harrison 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 39 KB

G.P.10.05 Successful long-term treatment

✍ B. Jordan; K. Eger; M. Deschauer; S. Zierz 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 48 KB

Sustained response to Rituximab in anti-

✍ Isabel Illa; Jordi Diaz-Manera; Ricard Rojas-Garcia; Jesus Pradas; Antonio Rey; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 172 KB

Long-term effect of intravenous immunogl

✍ A. Shibata-Hamaguchi; M. Samuraki; E. Furui; K. Iwasa; H. Yoshikawa; S. Hayashi; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB

Seronegative myasthenia gravis: comparis

✍ L. Padua; P. Tonali; I. Aprile; P. Caliandro; E. Bartoccioni; A. Evoli 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB

Muscle autoantibodies in subgroups of my

✍ Fredrik Romi; Geir Olve Skeie; Johan A. Aarli; Nils Erik Gilhus 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 126 KB